|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-1-23
|
|
pubmed:abstractText |
c-erbB-2 overexpression has been shown to be a potential marker of aggressive biological behaviour in a varity of tumours, whereas its role played in thyroid papillary thyroid carcinoma (PTC) remains unclear. Objective of the study is to determine whether c-erbB-2 overexpression correlates with the clinical course.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0029-5566
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
179-82, 184
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16395492-Adolescent,
pubmed-meshheading:16395492-Adult,
pubmed-meshheading:16395492-Aged,
pubmed-meshheading:16395492-Aged, 80 and over,
pubmed-meshheading:16395492-Carcinoma, Papillary,
pubmed-meshheading:16395492-Child,
pubmed-meshheading:16395492-Female,
pubmed-meshheading:16395492-Humans,
pubmed-meshheading:16395492-Immunohistochemistry,
pubmed-meshheading:16395492-Male,
pubmed-meshheading:16395492-Middle Aged,
pubmed-meshheading:16395492-Prognosis,
pubmed-meshheading:16395492-Receptor, erbB-2,
pubmed-meshheading:16395492-Recurrence,
pubmed-meshheading:16395492-Retrospective Studies,
pubmed-meshheading:16395492-Thyroid Neoplasms
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Prognostic value of c-erbB-2 expression in papillary thyroid carcinoma.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, University of Essen, Germany. lutz.freudenberg@uni-essen.de
|
|
pubmed:publicationType |
Journal Article
|
